Your child’s data could be used in ‘sophisticated’ identity fraud

Experts discuss how to spot and stop family data scams in this week’s Scam Watch with James Walker from Rightly and Louise Baxter from the National Trading Standards Scams Team.

• Watch out for phishing attacks that try to grab your login or bank details
• Choose strong, unique passwords for each online account and consider use of a password manager app to help you
• Use two-factor authentication whenever possible
• Don’t use unsecured Wi-Fi networks unless you have strong VPN software protection
• Use data breach notification services to learn if your details have been stolen in a known data breach

Johnson & Johnson Continues To Gain After LTL Agrees To Settle Talc Claims At $8.9 Bln

Johnson & Johnson (JNJ) shares continue to gain after its subsidiary LTL Management LLC yesterday re-filed for a reorganization plan and agreed to pay $8.9 billion to resolve all the current and future talc claims. Earlier, while filing bankruptcy filing in 2021, the company committed only $2 billion. LTL has secured commitments from over 60,000 current claimants to support a global resolution on these terms.

The shares have been trading positive since the end of March.

Currently, shares are at $163.19, up 3 percent from the previous close of $158.49 on a volume of 4,469,844.

Datadog Continues To Sink

Datadog, Inc. (DDOG) shares are down more than 6 percent on Wednesday morning trade, despite no corporate announcements today to influence the stock movement. The shares have been on a bearish trend since the start of the month and touched a 3-month low today.

Currently, shares are at $64.84, down 6.45 percent from the previous close of $69.32 on a volume of 1,635,941.

Albemarle Stock Slips 7% After Liontown Resources Reject $3.7 Bln Buyout Offer

Shares of Albemarle Corporation (ALB) are slipping over 7% on Wednesday morning after Liontown Resources rejects $3.7 billion buyout offer from the company.

ALB is currently trading at $194.45, down $15.12 or 7.21%, on the NYSE. The stock opened its trading at $200.96 after closing Tuesday’s trading at $209.57. The stock has traded between $185.15 and $334.55 in the past 52-week period.

Australian lithium miner Liontown Resources has rejected a $3.7 billion or A$5.5 billion takeover proposal from Albemarle, saying that it materially undervalues the company.

Albemarle confirmed that it submitted a non-binding proposal to acquire all outstanding shares of Liontown by way of scheme of arrangement for A$2.50 or $1.66 per share in cash.

Albemarle alleged on Monday that the Liontown Board has not meaningfully engaged with Albemarle to facilitate its shareholders receiving the benefits of the proposal.

Body found at Red Sky Condos in Aurora, police homicide investigators at scene

Aurora police homicide investigators on Wednesday were gathering evidence at the scene of a killing where a body was found.

The body was found in 14600 block of E. 2nd Avenue, according to an Aurora Police Department tweet. The location is south of East of 6th Avenue and east of Interstate 225.

“We are gathering details about the circumstances,” police officials said on Twitter.

No other information was released.

InflaRx Stock Surges 65% On FDA EUA For Gohibic For Treatment Of Critically Ill COVID-19 Patients

Shares of InflaRx N.V. (IFRX) are surging nearly 65% on Wednesday morning after it received the U.S. Food and Drug Administration’s Emergency Use Authorization for Gohibic (vilobelimab) for treatment of critically ill COVID-19 patients.

IFRX is currently trading at $6.22, up $2.45 or 64.92%, on the Nasdaq, on a huge volume of 32 million shares, above average volume of 0.3 million. The stock opened its trading at $5.01 after closing Tuesday’s trading at $3.77. The stock has traded between $0.78 and $5.92 in the past 52-week period.

Gohibic, known generically as Vilobelimab, is a first-in-class monoclonal anti-human complement factor C5a antibody.

The Emergency Use Authorization was based on Phase III clinical trial results showing a significant relative reduction in 28-day all-cause mortality of 23.9% with Gohibic compared to placebo in critically ill invasively mechanically ventilated COVID-19 patients.

The company is actively engaged in discussions with the FDA to determine the necessary steps for submitting a Biologics License Application for full approval of Gohibic.

European Economic News Preview: Germany Flash Inflation Data Due

Flash inflation from Germany and economic confidence survey results from euro area are the top economic news due on Thursday, headlining a busy day for the European economic news.

At 3.00 am ET, Spain’s statistical office INE publishes flash consumer and harmonized prices for March. Consumer price inflation is forecast to ease sharply to 3.8 percent from 6.0 percent in February.

In the meantime, Switzerland’s KOF leading index is due. The index is seen at 100.5 in March compared to 100.0 in February.

At 4.00 am ET, Italy’s ISTAT publishes unemployment data for February. Economists forecast the jobless rate to rise marginally to 8.0 percent from 7.9 percent in January.

At 5.00 am ET, the European Commission publishes euro area economic sentiment survey results. The economic confidence index is expected to rise slightly to 99.8 in March from 99.7 in February.

At 8.00 am ET, preliminary consumer price estimates are due from Germany. Economists expect consumer price inflation to ease notably to 7.3 percent in March from 8.7 percent in February.